Monoclonal Antibodies to Conserved Viral Epitopes for Current and Future Pandemics | 9 June 2021

Dr. James E. Crowe, Jr: Human Monoclonal Antibodies for SARS-CoV-2Подробнее

Monoclonal antibody treatment saving livesПодробнее

Viral Evolution and the Future of Monoclonal AntibodiesПодробнее

Towards antibody-based treatment of COVID-19 - A panel of human neutralizing mAbs targeting SARS...Подробнее

Vaccination, monoclonal antibody therapy, and SARS CoV-2 immune evasionПодробнее

John Altin: Analysis of Antibody Response to Conserved Spike Epitopes Following COVID-19 VaccinationПодробнее

Monoclonal Antibodies (mAbs) for Treatment and Prevention of COVID-19Подробнее

Engineering Optimized Anti SARS CoV 2 Antibody TherapeuticsПодробнее

Monoclonal Antibodies: Looking Beyond COVID-19Подробнее

Keynote Presentation: Discovery and Biology of Protective SARS-CoV-2 Human Monoclonal AntibodiesПодробнее

FREE Monoclonal Antibody Therapy (Regeneron) Orange County, CaliforniaПодробнее

BrisScience (April 2022): Creating treatments for future pandemics before they happenПодробнее

Dr. Laura Walker: Generation of Broad and Potent Neutralizing Antibodies to Speed Pandemic ResponsesПодробнее

Singapore signs deal with GSK to purchase coronavirus drug sotrovimabПодробнее

Laura Walker: "Broadly Neutralizing Antibodies to Speed Pandemic Responses" (12/8/21)Подробнее

The Future of Vaccines, Variants, and Treatment: The Vital Role of COVID-19 Monoclonal AntibodiesПодробнее

Keynote Presentation: Human Monoclonal Antibodies for Emerging AgentsПодробнее

What do you like about ELISpot? #antibodies #science #biotech #elispot #lifescienceПодробнее

2021 NSofT Symposium: Lynn Connolly, MD, PhDПодробнее